Medicare Enrolled
Dr. Mark Zuckerman, MD
Neurology · Smithtown, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zuckerman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zuckerman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zuckerman
Dr. Mark Zuckerman is a neurology specialist in Smithtown, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zuckerman performed 1,689 Medicare services across 1,162 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zuckerman received a total of $13,129 from 65 pharmaceutical and/or device companies across 514 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zuckerman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 20% volume in NY
$13,129 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,689
Medicare services
Top 20% in NY for neurology
1,162
Unique beneficiaries
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~89 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
589 | $110 | $375 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
367 | $78 | $250 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
145 | $90 | $400 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
100 | $145 | $500 |
| ECG, 1-3 leads with physician review A simple electrocardiogram recording using one to three leads. A physician reviews the results. |
86 | $6 | $20 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
67 | $158 | $500 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $120 | $400 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
49 | $196 | $800 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
43 | $366 | $621 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
36 | $109 | $500 |
| New patient office visit, complex (60-74 min) | 29 | $196 | $600 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
28 | $72 | $300 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
23 | $101 | $400 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
20 | $229 | $850 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
20 | $46 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $165 | $425 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
13 | $78 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,129
Total received (2018-2024)
Avg $1,876/year across 7 years
Top 22% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
514
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,010 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$119 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,914
2023
$2,362
2022
$1,819
2021
$1,890
2020
$1,314
2019
$2,101
2018
$1,730
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$212
ACADIA Pharmaceuticals Inc
$179
Medtronic, Inc.
$159
ABBVIE INC.
$137
Lundbeck LLC
$125
Biogen, Inc.
$111
ARGENX US, INC.
$109
Amneal Pharmaceuticals LLC
$97
Lilly USA, LLC
$93
Novartis Pharmaceuticals Corporation
$89
Neurocrine Biosciences, Inc.
$82
Otsuka America Pharmaceutical, Inc.
$77
PFIZER INC.
$64
MDD US Operations, LLC
$59
Teva Pharmaceuticals USA, Inc.
$56
MITSUBISHI TANABE PHARMA AMERICA, INC.
$54
Curonix LLC
$48
Genentech USA, Inc.
$47
UCB, Inc.
$27
Kyowa Kirin, Inc.
$26
Amylyx Pharmaceuticals, Inc.
$26
EMD Serono, Inc.
$21
AstraZeneca Pharmaceuticals LP
$16
Top 3 companies account for 28.7% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,355
ACADIA Pharmaceuticals Inc
$848
Neurocrine Biosciences, Inc.
$729
Teva Pharmaceuticals USA, Inc.
$720
UCB, Inc.
$705
Lundbeck LLC
$697
Alexion Pharmaceuticals, Inc.
$692
Amneal Pharmaceuticals LLC
$344
Kyowa Kirin, Inc.
$339
Otsuka America Pharmaceutical, Inc.
$336
AbbVie Inc.
$334
Lilly USA, LLC
$332
Amgen Inc.
$301
Eisai Inc.
$301
Adamas Pharmaceuticals, Inc.
$291
Supernus Pharmaceuticals, Inc.
$291
ABBVIE INC.
$273
Sunovion Pharmaceuticals Inc.
$239
Acorda Therapeutics, Inc
$234
Genentech USA, Inc.
$230
E.R. Squibb & Sons, L.L.C.
$204
Celgene Corporation
$194
Allergan, Inc.
$192
Novartis Pharmaceuticals Corporation
$188
Medtronic, Inc.
$180
MITSUBISHI TANABE PHARMA AMERICA, INC.
$177
PFIZER INC.
$169
EISAI INC.
$142
Boston Scientific Corporation
$132
EMD Serono, Inc.
$125
Avanir Pharmaceuticals, Inc.
$121
UPSHER-SMITH LABORATORIES LLC
$111
ARGENX US, INC.
$109
HARMONY BIOSCIENCES LLC
$109
Currax Pharmaceuticals LLC
$99
Biohaven Pharmaceutical Holding Company Ltd.
$95
Harmony Biosciences LLC
$88
Medtronic Vascular, Inc.
$86
MDD US Operations, LLC
$79
Avion Pharmaceuticals
$76
Grifols USA, LLC
$75
ARBOR PHARMACEUTICALS, INC.
$75
SK Life Science, Inc.
$68
Amylyx Pharmaceuticals, Inc.
$53
Almatica Pharma LLC
$49
Curonix LLC
$48
US WorldMeds, LLC
$48
IMPEL PHARMACEUTICALS INC.
$44
AstraZeneca Pharmaceuticals LP
$44
Allergan Inc.
$42
Alnylam Pharmaceuticals Inc.
$41
BOSTON SCIENTIFIC CORPORATION
$30
GE Healthcare
$27
Neurelis, Inc.
$24
Biohaven Pharmaceuticals, Inc.
$24
Upsher-Smith Laboratories LLC
$23
Nevro Corp.
$22
Mallinckrodt LLC
$21
GENZYME CORPORATION
$18
Strongbridge US INC.
$18
ASSERTIO THERAPEUTICS, Inc.
$16
Assertio Therapeutics, Inc.
$15
Promius Pharma LLC
$13
Arbor Pharmaceuticals, Inc.
$13
Medtronic USA, Inc.
$11
Top 3 companies account for 22.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CD HORIZON SPINAL SYSTEM · COMIRNATY · CONTRAVE · Dhivy · EMGALITY · Fycompa · GOCOVRI · GRALISE · Gamunex-C · General - Pain Management · Gocovri · Gralise · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LINQ II · MAVENCLAD · MYOBLOC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PAXLOVID · PLEGRIDY · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RYTARY · Reveal LINQ · Rystiggo · SOLIRIS · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
205
Per 100K population
13.4
County median income
$128,329
Nearest hospital
ST CATHERINE OF SIENA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zuckerman is a clinical cardiology specialist, with above-average Medicare volume (top 20% in NY), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zuckerman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zuckerman performed 589 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zuckerman receive payments from pharmaceutical companies?
Yes. Dr. Zuckerman received a total of $13,129 from 65 companies across 514 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zuckerman's costs compare to other neurologists in Smithtown?
Dr. Zuckerman's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zuckerman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Smithtown
Browse neurologists in Smithtown ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology